Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.47 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL873334 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL262657 | 1.00 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL2418959 | 0.94 | TSHR (0.60) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL2418958 | 0.94 | TSHR (0.60) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL10602340 | 0.94 | TSHR (0.60) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL23931119 | 0.92 | ALDH1A1 (0.50) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL10602355 | 0.92 | TSHR (0.63) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL4147264 | 0.92 | TSHR (0.63) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL10607403 | 0.92 | TSHR (0.63) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL1831155 | 0.92 | TSHR (0.63) | ALDH1A1ATMTSHRHCAR2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-RE45500-E1 | Polymeric network system for medical devices and methods of use | BIOINTERACTIONS LTD. (GB) | 2015-04-28 | — | — | US | claimed |
| JP-4791349-B2 | — | — | 2011-10-12 | — | — | JP | claimed |
| US-7655038-B2 | Polymeric network system for medical devices and methods of use | BIOINTERACTIONS LTD. (GB) | 2010-02-02 | — | — | US | claimed |
| EP-1421136-B1 | MASTERBATCH | GAUKROGER ANTHONY RICHARD (GB) | 2009-05-06 | — | — | EP | claimed |
| JP-2006519049-A | — | — | 2006-08-24 | — | — | JP | claimed |
| EP-1603603-A1 | POLYMERIC NETWORK SYSTEM FOR MEDICAL DEVICES AND METHODS OF USE | Biointeractions Ltd. (GB) | 2005-12-14 | — | — | EP | claimed |
| WO-2004075943-A1 | POLYMERIC NETWORK SYSTEM FOR MEDICAL DEVICES AND METHODS OF USE | BIOINTERACTIONS LTD. (GB) | 2004-09-10 | — | — | WO | claimed |
| US-20040170752-A1 | Polymeric network system for medical devices and methods of use | BIOINTERACTIONS LTD. (GB) | 2004-09-02 | — | — | US | claimed |
| EP-0375229-B1 | SURFACE TREATMENT OF PHOSPHOR PARTICLES AND METHOD FOR A CRT SCREEN | RCA Thomson Licensing Corporation (US) | 1993-08-11 | — | — | EP | claimed |
| EP-0375229-A2 | Surface treatment of phosphor particles and method for a CRT screen | RCA Thomson Licensing Corporation (US) | 1990-06-27 | — | — | EP | claimed |
| US-4095013-A | VINYL COPOLYMERS, ADHESIVES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1978-06-13 | — | — | US | claimed |
| CN-122005375-A | High-stability antiallergic collagen-chamomile active component hydrogel and large-scale preparation method and application thereof | 自然资源部第三海洋研究所 | 2026-05-12 | — | — | CN | disclosed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-4500729-A | ODORANT AND FLAVORS | GIVAUDAN CORPORATION (US) | 1985-02-19 | — | — | US | disclosed |
| US-4499114-A | UPGRADING ORGANOLEPTIC PROPERTIES TO SIMULATE RIPENESS; BEVERAGES | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1985-02-12 | — | — | US | disclosed |
| US-4381383-A | Process for producing polyolefins | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1983-04-26 | — | — | US | disclosed |
| US-4117110-A | GELS, DEODORIZERS | GLOBOL WERK GMBH (DE) | 1978-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | ALDH1A1 4813/4885ATM 420/4885TSHR 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.